MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$5,572K
Free Cash flow
-$5,462K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Loss on offering and change in f...
Accounts payable
Amortization of prepaid insuranc...
Others
Negative Cash Flow Breakdown
Accrued expenses
Change in fair value of publicly...
Payments on insurance financing ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-5,982
-4,351
-6,586
-6,482
Depreciation
74
73
80
76
Interest expense and amortization of debt discount on term loans (related party)
-
-
4
468
Stock-based compensation for services
32
44
-64
152
Amortization of prepaid insurance
236
227
226
245
Stock-based compensation
214
239
179
172
Loss on offering and change in fair value of private warrant liability
838
-2,005
155
339
Change in fair value of publicly traded warrant liability
-236
390
18
33
Change in fair value of forward purchase agreement warrant liability
-23
13
-12
-64
Change in fair value of forward purchase agreement warrant liability due to extension
-
-
24
-
Net change in operating lease (related party)
56
55
245
-90
Change in inventory reserve
14
12
-32
58
Accounts receivable, net
18
-3
-1
-8
Other receivable
0
-2
0
-1
Inventories
103
-44
-125
110
Prepaid expenses and other assets
-161
121
-66
32
Accounts payable
308
-1,220
412
1,006
Operating lease liability (related party)
-100
-52
-240
45
Accrued expenses
-911
664
623
-96
Product warranty liability
-16
-78
-41
-60
Other liability
-
-
-868
-
Net cash used in operating activities
-5,456
-6,061
-5,685
-4,331
Purchases of property and equipment
6
-
172
0
Net cash used in investing activities
-6
-
-172
0
Payments on insurance financing loans
213
208
191
167
Proceeds from the issuance of term loans (related party)
-
-
0
0
Proceeds from issuance of class a common stock under employee stock purchase plan
104
-
107
0
Dividends paid to stockholders of series a preferred stock
-
-
-1
0
Proceeds from exercise of forward purchase agreement warrants
-
-
2,953
158
Payment made for extinguishment of term loans (related party)
-
-
0
100
Proceeds from the issuance of class a common stock and investor warrants from registered direct offering
-
-
4,000
2,500
Proceeds from the issuance of class a common stock, issued pre-funded warrants, and series a warrants
0
29,997
0
210
Offering costs from the issuance of class a common stock, issued pre-funded warrants, and series a warrants
0
2,215
768
-
Deferred offering costs
-
-
62
-
Net cash provided by financing activities
-109
27,574
6,040
2,601
Effect of exchange rate changes on cash
-1
-1
0
-1
Net increase (decrease) in cash
-5,572
21,512
183
-1,731
Cash, beginning of period
25,251
3,739
3,556
5,483
Cash, end of period
19,679
25,251
3,739
3,556
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net increase
(decrease) in cash
-$5,572K
(-2742.86%↓ Y/Y)
Loss on offering and
change in fair value of...
$838K
Accounts payable
$308K
(1033.33%↑ Y/Y)
Amortization of prepaid
insurance
$236K
(-52.13%↓ Y/Y)
Stock-based compensation
$214K
(-30.07%↓ Y/Y)
Prepaid expenses and
other assets
-$161K
(-483.33%↓ Y/Y)
Depreciation
$74K
(-49.32%↓ Y/Y)
Net change in
operating lease (related...
$56K
(9.80%↑ Y/Y)
Stock-based compensation
for services
$32K
Change in inventory
reserve
$14K
(40.00%↑ Y/Y)
Proceeds from issuance of
class a common stock...
$104K
(35.06%↑ Y/Y)
Net cash used in
operating activities
-$5,456K
(33.34%↑ Y/Y)
Net cash provided by
financing activities
-$109K
(-101.36%↓ Y/Y)
Net cash used in
investing activities
-$6K
(14.29%↑ Y/Y)
Effect of exchange rate
changes on cash
-$1K
(-125.00%↓ Y/Y)
Canceled cashflow
$1,933K
Canceled cashflow
$104K
Net loss
-$5,982K
(44.03%↑ Y/Y)
Payments on insurance
financing loans
$213K
(-54.58%↓ Y/Y)
Purchases of property and
equipment
$6K
(-14.29%↓ Y/Y)
Accrued expenses
-$911K
(-391.99%↓ Y/Y)
Change in fair value of
publicly traded warrant...
-$236K
(-45.68%↓ Y/Y)
Inventories
$103K
(192.79%↑ Y/Y)
Operating lease liability
(related party)
-$100K
(-127.27%↓ Y/Y)
Change in fair value of
forward purchase...
-$23K
(94.98%↑ Y/Y)
Accounts receivable, net
$18K
(260.00%↑ Y/Y)
Product warranty
liability
-$16K
(73.33%↑ Y/Y)
Buy us a coffee
Envoy Medical, Inc. (COCH)
Envoy Medical, Inc. (COCH)